Viewing data from:

ACETAZOLAMIDE SODIUM

ANDA

ACETAZOLAMIDE SODIUM | A202693 | AVET LIFESCIENCES LTD

1 strength0 unique patents0 unique exclusivities

Medicare Part B Spending

CMS physician-administered drug spending for Acetazolamide Sodium (2023)

Total Spending

$986.30

Total Claims

Beneficiaries

ASP Price

—

HCPCS: J1120 — Injection, acetazolamide sodium, up to 500 mg

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

Products (1)

#001 — EQ 500MG BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Dec 19, 2014

No patent or exclusivity listings for this strength.